CoSyne Therapeutics
London, GB · Founded 2021 · 16 employees on LinkedIn · 5 known investors
Find your way into CoSyne Therapeutics
Sign up to see every warm intro you have to CoSyne Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the CoSyne Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cosyne operates a platform that combines biology, computation, and finance, using a hub-and-spoke model to spin out assets into subsidiaries as a distributed portfolio approach. The company operates laboratories focused on computational and experimental work across London, Cambridge, and New York.
Founders & leadership
CoSyne Therapeutics was founded in 2021 by Michael Johnson.
MJ
Michael JohnsonCMO & Co-Founder
Investors · 5
Backedlisted by BackedLondon · $500K – $5M
How we know: Backed's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
Frequently asked questions
- What does CoSyne Therapeutics do?
- Cosyne operates a platform that combines biology, computation, and finance, using a hub-and-spoke model to spin out assets into subsidiaries as a distributed portfolio approach. The company operates laboratories focused on computational and experimental work across London, Cambridge, and New York.
- Who founded CoSyne Therapeutics?
- CoSyne Therapeutics was founded by Michael Johnson in 2021.
- Who are CoSyne Therapeutics's investors?
- CoSyne Therapeutics's investors include Backed, BY Venture Partners, Crane Venture Partners, LocalGlobe, ARC VENTURES.
- Where is CoSyne Therapeutics headquartered?
- CoSyne Therapeutics is headquartered in London, GB.





